ORASURE TECHNOLOGIES, INC Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
ORASURE TECHNOLOGIES, INC (OSUR) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of -$253.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2022-03-01
- ORASURE TECHNOLOGIES, INC accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2021 was -$253.00K, a 126.89% decline from fiscal 2020.
- ORASURE TECHNOLOGIES, INC accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2020 was $941.00K, a 58.14% decline from fiscal 2019.
- ORASURE TECHNOLOGIES, INC accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2019 was $2.25M.
- ORASURE TECHNOLOGIES, INC accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2018 was -$53.00K, a 130.81% decline from fiscal 2017.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month as first filed |
|---|---|---|
| 2021-12-31 | -$253.00K 10-K · filed 2022-03-01 | |
| 2020-12-31 | $941.00K 10-K · filed 2022-03-01 | |
| 2019-12-31 | $2.25M 10-K · filed 2022-03-01 | $2.23M 10-K · filed 2020-03-02 |
| 2018-12-31 | -$53.00K 10-K · filed 2021-03-01 | -$27.00K 10-K · filed 2019-02-28 |
| 2017-12-31 | $172.00K 10-K · filed 2020-03-02 | |
| 2016-12-31 | $40.00K 10-K · filed 2019-02-28 | |
| 2015-12-31 | $341.00K 10-K · filed 2018-02-28 | |
| 2014-12-31 | $253.00K 10-K · filed 2017-03-14 | |
| 2013-12-31 | $18.00K 10-K · filed 2016-03-14 | |
| 2012-12-31 | $115.00K 10-K · filed 2015-03-12 | |
| 2011-12-31 | $64.00K 10-K · filed 2014-03-14 | |
| 2010-12-31 | $115.00K 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |